Hansa Biopharma Poised for Full EMA Approval of Idefirix Following Landmark Post-Authorisation Study
Hansa Biopharma Poised for Full EMA Approval of Idefirix Following Landmark Post-Authorisation Study
Hansa Biopharma is preparing to submit an application to the European Medicines Agency (EMA) to convert the...
